Tasked to expand CircleDNA into leading consumer preventive healthcare platformPrenetics Global Ltd a Nasdaq listed genomics and precision oncology company, has announced the appointment of Joel Neoh
Joel’s appointment comes as Prenetics is forging ahead to reinvent the preventive healthcare landscape, with a focus on harmonizing consumer health and genetics, breakthrough technology for early cancer detection, and targeted therapy for cancer treatment. As part of the company’s transformation, it seeks to significantly expand into new verticals and introduce new personalized healthcare offerings to consumers within CircleDNA.
"As an entrepreneur who has received significant support, particularly in Southeast Asia, I feel a strong desire to contribute back to the community by promoting health and emphasising the importance of preventive care," Joel added. “I'm learning an incredible amount each day about genetics, healthcare, new cancer technology, and the wealth of invaluable insights offered by our scientist community has been eye-opening. It's been a truly remarkable experience that I'm eager to share more about in due time.